Navigation Links
LifeCare Holdings, Inc. Announces Year-end Results
Date:3/28/2008

PLANO, Texas, March 28 /PRNewswire/ -- LifeCare Holdings, Inc. (the "Company") today announced its operating results for the three months and year ended December 31, 2007.

Three Months Ended December 31, 2007

Net Revenues

Our net patient service revenue of $79.7 million for the three months ended December 31, 2007, decreased by $0.1 million as compared to the same period in 2006. Patient days increased by 1,027, or 1.8%, and admissions increased by 32, or 1.5%, during the 2007 period. During the three months ended December 31, 2007, our net patient service revenue per patient day was $1,390 as compared to $1,416 per patient day for the same period in 2006, which represents a decrease of 1.8%. This decrease on a per patient day basis was primarily the result of the recent unfavorable reimbursement changes implemented by CMS during 2007, partially offset by an increase in the percentage of our revenues generated from commercial payors.

Expenses

Total expenses increased by $17.1 million to $117.4 million for the three months ended December 31, 2007 as compared to $100.3 million for the comparable period in 2006. Included in expenses for the 2007 and 2006 periods are impairment charges of $35.0 million and $19.0 million, respectively. Excluding the impairment charges, expenses increased by $1.1 million to $82.4 million for the 2007 period as compared to $81.3 million for the 2006 period.

Rent expense increased by $1.4 million during the 2007 period in connection with an 11.5% increase in average licensed bed capacity. The provision for doubtful accounts decreased by $2.9 million during the 2007 period as compared to the same period in 2006 due primarily to a $1.7 million charge for the impact of a conversion to a new patient accounting system during the 2006 period.

Net interest expense increased by $1.2 million during the 2007 period as the result of the increase in LIBOR rates during 2007 and the increased margin

%

2006 2007 Change

Net patient service revenue $79,868 $79,739 -0.2%

Expenses:

Salaries, wages and benefits 36,765 38,521 4.8%

Supplies 7,281 8,509 16.9%

Rent 4,541 5,953 31.1%

Other operating expense 17,087 16,970 -0.7%

Provision for doubtful accounts 3,385 453 -86.6%

Depreciation and amortization 3,054 2,570 -15.8%

Goodwill impairment charges 19,000 35,000 84.2%

Long-lived asset impairment charges 945 - NM

Interest expense, net 8,234 9,445 14.7%

100,292 117,421 17.1%

Operating loss (20,424) (37,682) 84.5%

Equity in loss of joint venture - (246) NM

Loss before income taxes (20,424) (37,928) 85.7%

Provision for (benefit from) income

taxes (802) 2,729 -440.3%

Net loss $(19,622) $(40,657) 107.2%

Reconciliation to Credit Agreement

EBITDA:

Operating loss - per above $(20,424) $(37,682)

Adjusted for:

Interest expense, net 8,234 9,445

Depreciation and amortization 3,054 2,570

Goodwill impairment charges 19,000 35,000

Stock compensation expense 164 169

Cost saving initiatives - 320

Hospital closure/relocation/start-up

losses 1,602 2,799

Sarbanes Oxley implementation - 366

New Orleans operations 297 (6)

Other credit agreement add-back items 406 127

Credit Agreement EBITDA $12,333 $13,108

Schedule 2

Condensed Consolidated Statements of Operations

For the Year-Ended December 31, 2006 and 2007

(In thousands)

(Unaudited)

%

2006 2007 Change

Net patient service revenue $325,882 $322,215 -1.1%

Expenses:

Salaries, wages and benefits 145,340 156,125 7.4%

Supplies 32,144 33,460 4.1%

Rent 18,080 21,644 19.7%

Other operating expense 77,206 80,257 4.0%

Provision for doubtful accounts 7,673 4,740 -38.2%

Depreciation and amortization 11,856 11,254 -5.1%

Goodwill impairment charges 43,600 38,834 -10.9%

Insurance recovery (5,333) - NM

Gain on early extinguishment of debt (1,329) - NM

Loss of disposition of assets 945 - NM

Interest expense, net 32,819 35,911 9.4%

363,001 382,225 5.3%

Operating loss (37,119) (60,010) 61.7%

Equity in loss of joint venture - (695) NM

Loss before income taxes (37,119) (60,705) 63.5%

Provision for income taxes 3,707 77 -97.9%

Net loss $(40,826) $(60,782) 48.9%

Reconciliation to Credit Agreement

EBITDA:

Operating loss - per above $(37,119) $(60,010)

Adjusted for:

Gain on early extinguishment

of debt (1,329) -

Loss of disposition of assets 945 -

Interest expense, net 32,819 35,911

Depreciation and amortization 11,856 11,254

Goodwill impairment charge 43,600 38,834

Stock compensation expense 632 695

Severance - 2,918

Cost report adjustment 3,871 -

Cost saving initiatives - 3,648

Hospital closure/relocation/

start-up losses 3,198 5,967

Sarbanes Oxley implementation - 1,477

New Orleans operations, net of

proceeds (3,573) 86

Other credit agreement add-back

items 2,850 713

Credit Agreement EBITDA 57,750 41,493

Exercise of cure right for quarter

ended September 30, 2007 - 5,999

Pro Forma Credit Agreement EBITDA $57,750 $47,492

Schedule 3

Condensed Consolidated Balance Sheets

(In thousands)

(Unaudited)

December 31, December 31,

Assets 2006 2007

Current assets:

Cash and cash equivalents $33,250 $17,816

Accounts receivable, net 67,464 66,911

Income taxes receivable 6,418 2,025

Other current assets 17,662 13,597

Total current assets 124,794 100,349

Property and equipment, net 78,418 83,317

Goodwill and other identifiable

intangibles, net 318,745 282,415

Other assets 14,461 15,675

$536,418 $481,756

Liabilities and Stockholder's Equity

Current liabilities:

Payables and accruals $45,346 $42,285

Estimated third-party payer settlements 8,308 5,744

Current installments of long-term debt 3,188 2,550

Current installments of obligations under

capital leases 3,925 1,604

Total current liabilities 60,767 52,183

Long-term debt, excluding current

installments 396,262 393,713

Obligations under capital leases,

excluding current installments 1,909 741

Lease financing obligation - 16,590

Accrued insurance 5,902 4,714

Other noncurrent liabilities 21,080 13,582

Total liabilities 485,920 481,523

Stockholder's equity 50,498 233

$536,418 $481,756

Schedule 4

Condensed Consolidated Statements of Cash Flows

For the year-ended December 31, 2006 and 2007

(In thousands)

(Unaudited)

2006 2007

Cash flows from operating activities:

Net loss $(40,826) $(60,782)

Adjustments to reconcile net loss

to net cash provided by (used in)

operating activities:

Depreciation and amortization 13,102 12,893

Provision for doubtful accounts 7,673 4,740

Impairment charges 43,600 38,834

Gain on early extinguishment of debt (1,329) -

Loss on disposition of asset 945 -

Equity in loss of joint venture - 695

Deferred income taxes (2,524) 1,695

Equity compensation amortization 632 684

Changes in operating assets and

liabilities:

Patient accounts receivable (11,854) (4,187)

Other current assets 15,150 4,006

Other assets (1,209) 77

Estimated third-party payer settlements 16,574 (2,564)

Accounts payable and accrued expenses 5,962 (5,353)

Other liabilities 3,777 (589)

Net cash provided by (used in)

operating activities 49,673 (9,851)

Cash used in investing activities:

Purchases of property and equipment (28,235) (47,480)

Sale leaseback proceeds 788 31,104

Net cash used in investing activities (27,447) (16,376)

Cash flows provided by (used in)

financing activities:

Deferred financing costs - (3,142)

Lease financing obligation proceeds - 15,113

Equity contribution from parent - 5,999

Payments of notes payable and long-term debt (3,443) (3,188)

Payments on obligations under capital leases (5,376) (3,989)

Net cash provided by (used in)

financing activities (8,819) 10,793

Net increase (decrease) in cash and cash

equivalents 13,407 (15,434)

Cash and cash equivalents, beginning of period 19,843 33,250

Cash and cash equivalents, end of period $33,250 $17,816

Schedule 5

Selected Operating Statistics

Three months Three months

ended December 31, ended December 31,

2006 2007

Number of hospitals within hospitals

(end of period) 12 9

Number of freestanding hospitals

(end of period) 8 10

Number of total hospitals (end of

period) 20 19

Licensed beds (end of period) 926 1,009

Average licensed beds (1) 905 1,009

Admissions 2,099 2,131

Patient days 56,410 57,437

Occupancy rate 67.8% 61.9%

Percent net patient service revenue

from Medicare 72.1% 64.0%

Percent net patient service revenue

from commercial payors and

Medicaid (2) 27.9% 36.0%

Net patient service revenue per

patient day $1,416 $1,390

Year-ended Year-ended

ended December 31, ended December 31,

2006 2007

Number of hospitals within hospitals

(end of period) 12 9

Number of freestanding hospitals

(end of period) 8 10

Number of total hospitals (end of

period) 20 19

Licensed beds (end of period) 926 1,009

Average licensed beds (1) 889 961

Admissions 8,318 7,999

Patient days 226,863 229,479

Occupancy rate 69.9% 65.4%

Percent net patient service revenue

from Medicare 71.6% 64.6%

Percent net patient service revenue

from commercial payors

and Medicaid (2) 28.4% 35.4%

Net patient service revenue per

patient day $1,436 $1,404

(1) The licensed beds are only calculated on the beds at locations that

were open for operations during the applicable periods.

(2) The percentage of net patient service revenue from Medicaid is less

than one percent for each of the periods presented.

spread as the result of the amendments to our senior secured credit facility, as discussed further in the Liquidity and Capital Resources section below. The remaining unfavorable variance of $1.4 million was related mainly to the increases in salaries, wages and benefits, supplies incurred as the result of inflationary increases and the increases in bed capacity.

Credit Agreement EBITDA

For the quarter ended December 31, 2007, adjusted EBITDA as defined in the credit agreement for our senior secured credit facility, which we refer to as Credit Agreement EBITDA, was $13.1 million, which is an increase of $0.8 million, or 6.5% from the prior year period. Credit Agreement EBITDA reflects the elimination of goodwill impairment charges, start-up costs and certain other non-recurring/operational expenditures as defined in our credit agreement.

Year Ended December 31, 2007

Net Revenues

Our net patient service revenue decreased by $3.7 million, or 1.1%, for the year-ended December 31, 2007, to $322.2 million from $325.9 million for the comparable period in 2006.

The decrease in net patient service revenue included an unfavorable $9.5 million variance as the result of decreased revenue per patient day, offset by a $2.7 million favorable benefit from an increase in patient days and a net increase of $3.1 million attributable to a decrease in unfavorable adjustments related to previously filed cost reports. Patient days in 2007 were 2,616 greater, or 1.2% greater, than the same period in 2006. The increase in patient days was partially attributable to the expansion of our operations during 2007.

During the years ended December 31, 2007 and 2006, we recorded reductions in net patient service revenue of $1.2 million and $4.3 million, respectively, related to changes in estimates and settlements on cost reports filed with the Medicare program. The adjustment recognized during the year ended December 31, 2006 related primarily to two of the Company's hospitals. In these cases, the actual cost to charge ratio, which is used to determine the reimbursement for short stay and high cost outliers, was outside the 10% limit of the cost to charge ratio amount used by CMS to process interim claims such that it resulted in a reconciliation of payments to the actual cost to charge ratio for these cost report periods.

Our net patient service revenue per patient day as reported during the years ended December 31, 2007 and 2006 was $1,404 and $1,436, respectively. However, exclusive of the cost report reimbursement adjustments discussed previously, net patient service revenue per patient day for the years ended December 31, 2007 and 2006 was $1,420 and $1,455, respectively, or a decrease of 2.4%. The decrease in net patient service revenue per patient day, excluding the impact of the cost report reimbursement adjustment, was primarily the result of the unfavorable reimbursement changes, including payment methodology changes and reductions in DRG weights, implemented by CMS during the latter half of 2006 and during 2007, partially offset by an increase in the percentage of our revenues generated from commercial payors.

Total Expenses

Total expenses increased by $19.2 million to $382.2 million for the year- ended December 31, 2007 as compared to $363.0 million for the comparable period in 2006. Included in the expenses for the year ending December 31, 2007, is a $38.8 million impairment charge related to goodwill and $2.5 million attributable to compensation and benefits accrued in connection with the departure of our former CEO. Included in the expenses for the 2006 period is an impairment charge of $43.6 million related to goodwill, a gain of $1.3 million related to the early extinguishment of debt, and $5.3 million in insurance recoveries related to Hurricane Katrina. Gain on early extinguishment of debt for the year-ended December 31, 2006 was the result of our repurchasing $3 million in face of our senior subordinated notes for approximately $1.5 million. Partially offsetting the gain was the write-off of capitalized financing cost of $0.1 million recorded in connection with the retirement of these senior subordinated notes.

Excluding the impairment charge and the compensation and benefits accrual for 2007, and the impairment charge, gain on early extinguishment of debt, and the insurance recovery for 2006, expenses increased by $14.9 million from the same period in prior year. Rent expense increased by $3.6 million during the 2007 period in connection with the increases in bed capacity during 2007. Net interest expense increased by $3.1 million during the 2007 period as a result of an increase in the LIBOR rates during 2007 and in the margin spread as the result of the amendments to our senior secured credit facility discussed in the Liquidity and Capital Resources section below. The remaining $8.2 million increase in expenses was primarily attributable to an increase in salaries, wages and benefits of $8.3 million, and an increase in outside services, contract labor and other operating expenses of $3.1 million. These increases resulted from inflation and the increases in bed capacity during 2007. These increases were offset by a decrease in the provision for doubtful accounts of $2.9 million and a decrease in depreciation and amortization expense of $0.6 million. The provision for doubtful accounts during 2006 included an additional provision of $1.7 million for the impact of a conversion to a new patient accounting system during 2006.

Credit Agreement EBITDA

For the year-ended December 31, 2007, Credit Agreement EBITDA, was $47.5 million, including a $6 million cure amount discussed below, a decrease of $10.3 million, or 17.8% from the prior year period. The decrease in Credit Agreement EBITDA, on a dollar and percentage of net patient service revenue basis, was primarily due to the reduction in revenues associated with the CMS regulatory changes and the increase in expenses discussed previously. As of December 31, 2007, we believe we were in compliance with all covenants contained in our senior secured credit facility, as amended.

Liquidity and Capital Resources

At December 31, 2007, our outstanding indebtedness consisted of $147.0 million aggregate principal amount of senior subordinated notes due 2013, and a $249.3 million term loan facility that matures in 2012.

The senior secured credit facility requires us to comply on a quarterly basis with certain financial covenants, including an interest coverage ratio test and a maximum leverage ratio test, which will become more restrictive over time. In addition, the senior secured credit facility includes various negative covenants, including limitations on indebtedness, liens, investments, permitted businesses, restricted payments, transactions with affiliates and other matters, as well as certain customary representations and warranties, affirmative covenants and events of default including payment defaults.

The interest rates per annum applicable to loans, other than swingline loans, under our senior secured credit facility, as amended are, at our option, equal to either an alternate base rate or an adjusted LIBOR rate for a one-, two-, three- or six-month interest period, or a nine- or twelve-month period if available, in each case, plus an applicable margin. The applicable margins on the loans, as amended, as of December 31, 2007 are (1) 3.25% for alternate base rate revolving loans, (2) 4.25% for adjusted LIBOR revolving loans, (3) 3.25% for alternate base rate term loans, and (4) 4.25% for adjusted LIBOR term loans. These margins are subject to reduction based upon the ratio of our total indebtedness to our consolidated adjusted EBITDA (as defined in the credit agreement governing our senior secured credit facility, as amended). At December 31, 2007, the interest rate applicable to the $249.9 million under our term loan facility was 9.45%.

On May 2, 2007, we entered into Amendment No. 1 to our senior secured credit facility ("Amendment No. 1"), which modified certain financial covenants effective March 31, 2007 and increased the spread on the variable interest rate to be paid by the Company. Based upon amounts outstanding under the senior secured credit facility and the applicable margins at the time of the amendment, we estimated that the increase in the spread on the variable interest rate would result in additional annual interest expense of approximately $1.9 million.

As of September 30, 2007, we were not in compliance with the financial covenant requirements as set forth in our senior secured credit facility. However, this event of non-compliance was cured on November 14, 2007 through the exercise of a cure right as provided for in the credit agreement. The cure right provides us the right to issue permitted cure securities in exchange for cash or otherwise receive cash that would be contributed to our capital in an amount that is necessary to satisfy the financial covenant requirement on a pro-forma basis. The cure right capital contribution amount is considered additional consolidated EBITDA, as defined in our credit agreement, for purposes of measuring compliance with the financial covenants for our fiscal quarter ended September 30, 2007. In subsequent periods, this cure amount will continue to be considered a component of consolidated EBITDA on a trailing 4 quarter calculation basis. Additionally, the cure amount is limited such that it can be no greater than the amount required for purposes of complying with the financial covenants in the quarter in which it is exercised nor can this cure right be exercised more than two times in any trailing 4 quarter period, with the exception of two additional cure rights that were included in Amendment No. 2 discussed below.

The cure right cash contribution of $6 million necessary to cure our non- compliance with the financial covenants tested as of September 30, 2007, was received by our parent company from affiliates of The Carlyle Group, on November 14, 2007. Our parent company in turn contributed these funds to the capital of the Company through certain intermediate subsidiaries. As a result of the exercise of this cure, we were deemed to have met the financial covenants contained in our senior secured credit facility as of September 30, 2007.

On December 6, 2007, we entered into Amendment No. 2 to the Company's senior secured credit facility ("Amendment No. 2"), which modified certain financial covenants starting for the period ending December 31, 2007, further increased the spread on the variable interest rate, and reduced the revolving credit facility to $60 million from $75 million. Additionally, Amendment No. 2 designated up to two additional cure rights that can be exercised at any time during the term of the loan, provided that for quarters ending on or after June 30, 2008, the leverage ratio, as defined in the credit agreement, on the last day of such fiscal quarter is not more than 0.50 to 1.00 above the leverage ratio requirement for such quarter. Based upon amounts outstanding under the senior secured credit facility and the applicable margins at the time of the amendment, we estimated that the increase in the spread on the variable interest rate would result in additional annual interest expense of approximately $2.5 million. This is in addition to the estimated increase in interest expense pursuant to Amendment No. 1.

We may not able to continue to satisfy the covenant requirements in subsequent periods. If we are unable to maintain compliance with the covenants contained in our senior secured credit facility, an event of default would occur. During the continuation of an event of default, the lenders under the senior secured credit facility are entitled to take various actions, including accelerating amounts due under the senior secured credit facility, terminating our access to our revolving credit facility and all other actions generally available to a secured creditor. An uncured event of default would have a material adverse effect on our financial position, results of operations and cash flow.

We believe that our cash on hand, expected cash flows from operations, potential availability of borrowings under the revolving portion of our senior secured credit facility, and funds available under a master lease agreement will be sufficient to finance our operations, and meet our scheduled debt service requirements for at least the next twelve months.

Forward-Looking Statements

This press release includes forward-looking statements regarding, among other items, operations, proposed regulations and their possible effect on the Company's results. Such statements are subject to a number of uncertainties and risks that could significantly affect current plans. Furthermore, actual results may differ materially from those experienced or implied by such forward-looking statements. Factors that could cause results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, risks relating to operating in a regulated environment, failure to maintain compliance with our debt covenants, implementing our business plan, maintaining relationships with physicians in our markets, availability of sufficient nurses and therapists, competition, retaining key management, ability to service our debt requirements, litigation matters and availability of insurance. Further information about factors that could affect the Company's financial and other results is included in our Form 10-K as filed on March 28, 2008, which can be viewed on the SEC's website. Many of the factors that will determine the Company's future results are beyond the ability of management to control or predict. As a result, you should not place undue reliance on forward-looking statements, which reflect management's views only as the date hereof. The Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements whether as a result of new information, future events or otherwise.

Non-GAAP Financial Measures

Credit Agreement EBITDA is used in the calculations of the interest coverage and leverage ratios that are included in the covenants contained in our existing senior secured credit agreement. Credit Agreement EBITDA is not a measure of financial performance computed in accordance with GAAP and should not be considered in isolation or as a substitute for operating income, net income, cash flows from operations or other statement of operations or cash flow data prepared in conformity with GAAP, or as measures of profitability or liquidity. In addition the calculation of Credit Agreement EBITDA is susceptible to varying interpretations and calculation, and the amounts presented may not be comparable to similarly titled measures of other companies. Credit Agreement EBITDA may not be indicative of historical operating results, and we do not mean for it to be predictive of future results of operations or cash flows. For the trailing 12-month period ended December 31, 2007, Credit Agreement EBITDA was $47.5 million, including the $6 million cure amount discussed previously.

LifeCare, based in Plano, Texas, operates 19 long term acute care hospitals located in nine states. Long term acute care hospitals specialize in the treatment of medically complex patients who typically require extended hospitalization. For more information on LifeCare, visit our website at http://www.lifecare-hospitals.com.

Schedule 1

Condensed Consolidated Statements of Operations

For the Three Months Ended December 31, 2006 and 2007

(In thousands)

(Unaudited)


'/>"/>
SOURCE LifeCare Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. LifeCare Hospitals of Wisconsin Unveils Center for Advanced Wound Healing
2. LifeCare Holdings, Inc. Announces Third Quarter Results
3. Batesville Holdings, Inc., Appoints Doug Wilson Senior Vice President Human Resources
4. Previously Disclosed Changes in Board Composition of NightHawk Radiology Holdings, Inc. Prompt Notice of Noncompliance from the Nasdaq Global Market
5. Solera Holdings, Inc. Appoints Jason Brady as General Counsel
6. Duane Reade Holdings, Inc. to Report Fourth Quarter and Full Year 2007 Financial Results
7. Whitemark Homes Signs Letter of Intent to Acquire Metiscan Holdings, Inc.
8. Vallon Holdings, LLC Launches New Subsidiary Focused on Contract Resources for the Minneapolis-St. Paul Life Science Industry
9. NightHawk Radiology Holdings, Inc. Announces Board Member Departure
10. NightHawk Radiology Holdings, Inc. to Speak at the Cowen and Company 28th Annual Health Care Conference on March 18, 2008
11. Lixte Biotechnology Holdings, Inc. Announces Further Developments Regarding the Anti-Cancer Activity of Its Patent-Pending Proprietary Compounds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... ... February 11, 2016 , ... The Commission for ... the Board of Commissioners. Individuals interested in volunteer board service are encouraged to ... clinical practice settings and across allied health to contribute to its mission and ...
(Date:2/11/2016)... ... ... Colorado spine surgeon, Donald Corenman, MD, DC has been selected by ... . The list consists of spine surgeons across the country nominated by their peers ... importance of clinical excellence; he has been awarded the Patient’s Choice Award, Compassionate Doctor ...
(Date:2/11/2016)... ... ... The annual list showcases the 20 Most Promising SharePoint Solution Providers in 2015. ... to the SharePoint ecosystem. A panel of experts and members of CIOReview’s editorial board ... promote technology entrepreneurship. , The survey was made at the end of the ...
(Date:2/11/2016)... ... February 11, 2016 , ... Husted Kicking has completed its Third ... February 6th & 7th, 2016 according to kicking coach Michael Husted. , “This event ... the NFL’s combine in Indianapolis,” says Husted. “The NFL uses a third party organization ...
(Date:2/10/2016)... ... February 10, 2016 , ... President Obama’s budget ... organizations to deliver medical services via telehealth, estimated to generate more than $160 ... such language for many years. Although there is more to be done, ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... , February 11, 2016 ... at Worldwide Clinical Trials, will present at this year,s Summit ... the Hyatt Regency in Miami, FL. ... partnerships to optimize study execution, supporting SCOPE,s "Improving Site Study ... take place on Thursday, Feb. 25 at 11:05 a.m. ...
(Date:2/11/2016)... Fla. , Feb. 11, 2016 ... ) company providing high-quality specialty pharmacy care for ... announced today it has achieved full Specialty Pharmacy ... accrediting organization dedicated to promoting health care quality ... --> --> The URAC accreditation ...
(Date:2/11/2016)... 11, 2016 SI-BONE, Inc., a medical ... iFuse Implant System, a minimally invasive surgical (MIS) ... the sacroiliac (SI) joint, announced the publication of ... MIS SI joint fusion for patients suffering from ... or SI joint disruption.  In the first article, ...
Breaking Medicine Technology: